Skip to main content

Table 1 Distribution of specific KRAS mutations in 17 cases

From: Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer

Mutation

Amino acid

N

%

%

GGT → GAT

gly12 → asp12

5

 

29

GGT → TGT

gly12 → cys12

1

 

6

GGT → GTT

Gly12 → val12

5

 

29

GGT → GCT

gly12 → alanin12

2

 

12

GGT → AGT

gly12 → ser12

2

 

12

GGT → CGT

gly12 → arg12

1

 

6

GGT → GAC

gly13 → asp13

1

 

6

 

Total

17

 

100